Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 14, 2018 - Issue 12
Submit an article Journal homepage
331
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson’s disease

Fabrizio StocchiDepartement of Neurology, University and Institute for Research and Medical Care, San Raffaele Rome, Roma, ItalyCorrespondence[email protected] [email protected]
View further author information
,
Laura VaccaDepartment of Neurorehabilitation Sciences, Casa Cura Policlinico (CCP), Milan, ItalyView further author information
,
Paola StirpeDepartement of Neurology, University and Institute for Research and Medical Care, San Raffaele Rome, Roma, ItalyView further author information
&
Margherita TortiDepartement of Neurology, University and Institute for Research and Medical Care, San Raffaele Rome, Roma, Italy;Departement of Neurology, Institute for Research and Medical Care, San Raffaele Cassino, Cassino (FR), ItalyView further author information
Pages 1189-1195 | Received 08 Apr 2018, Accepted 16 Nov 2018, Published online: 02 Dec 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Fabrizio Stocchi, Laura Vacca, Andrea Grassi & Margherita Torti. (2021) An evaluation of the efficacy and value of CVT-301 for the treatment of Parkinson’s disease. Expert Opinion on Pharmacotherapy 22:8, pages 965-972.
Read now
Danielle S. Shpiner, Sagari Bette, Daniel G. Di Luca & Jason Margolesky. (2019) CVT-301 for the treatment of Parkinson’s disease. Expert Review of Neurotherapeutics 19:7, pages 603-611.
Read now

Articles from other publishers (13)

Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
Ritam Bandopadhyay, Nainshi Mishra, Ruhi Rana, Gagandeep Kaur, Mohammed M. Ghoneim, Sultan Alshehri, Gulam Mustafa, Javed Ahmad, Nabil. A. Alhakamy & Awanish Mishra. (2022) Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence. Frontiers in Pharmacology 13.
Crossref
Mohammad Al Majali, Michael Sunnaa & Pratap Chand. (2021) Emerging Pharmacotherapies for Motor Symptoms in Parkinson’s Disease. Journal of Geriatric Psychiatry and Neurology 34:4, pages 263-273.
Crossref
Joseph Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn & Jennifer Goldman. 2021. Principles and Practice of Movement Disorders. Principles and Practice of Movement Disorders 164 203.e14 .
Gerard Saranza & Anthony E. Lang. (2020) Inhaled Levodopa as a Potential Treatment for Diphasic Dyskinesia. Movement Disorders 36:1, pages 265-266.
Crossref
Nadia Mouchaileh & Andrew J. Hughes. (2020) Pharmacological management of Parkinson’s disease in older people. Journal of Pharmacy Practice and Research 50:5, pages 445-454.
Crossref
Beth E. Safirstein, Aaron Ellenbogen, Ping Zhao, Herbert R. HenneyIIIIII, Deena M. Kegler-Ebo & Charles Oh. (2020) Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease. Clinical Therapeutics 42:6, pages 1034-1046.
Crossref
Mahasweta Paul & Raymond Lau. (2020) Potentials and challenges of Levodopa particle formulation for treatment of Parkinson’s disease through intranasal and pulmonary delivery. Advanced Powder Technology 31:6, pages 2357-2365.
Crossref
Julia Paik. (2020) Levodopa Inhalation Powder: A Review in Parkinson’s Disease. Drugs 80:8, pages 821-828.
Crossref
Rongrong Xu, Wenwen Zhao, Lan Yu, Qijun Chen, Xiaolu Hu, Yinying Ba, Xiaoqing Chen, Xing Wang & Xia Wu. (2019) A selective and sensitive UFLC-MS/MS method for the simultaneous determination of five alkaloids from Piper longum L. and its application in the pharmacokinetic study of 6-OHDA-induced Parkinson's disease rats . RSC Advances 9:63, pages 37082-37091.
Crossref
Michael W Hayes, Victor SC Fung, Thomas E Kimber & John D O'Sullivan. (2019) Updates and advances in the treatment of Parkinson disease. Medical Journal of Australia 211:6, pages 277-283.
Crossref
M. Luinstra, V. Isufi, L. de Jong, A.W.F. Rutgers, P. Hagedoorn, J. Puttenstein, T. van Laar & H.W. Frijlink. (2019) Learning from Parkinson’s patients: Usability of the Cyclops dry powder inhaler. International Journal of Pharmaceutics 567, pages 118493.
Crossref
Martin Klietz, Stephan Greten, Florian Wegner & Günter U. Höglinger. (2019) Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients. Drugs & Aging 36:6, pages 511-530.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.